Time to talk global vaccine exports - a topic where data availability (hopefully) will soon improve as opportunities for "vaccine diplomacy" emerge and - despite the Indian tragedy and glaring global inequalities in vacc access, the news is generally quite good. A 🧵
2) Best news (H/T @ChadBown) is that @pfizer is now FINALLY starting to fulfill international contracts also from US located production, following the (alleged) expiry of de facto contractual bans on doing so. Up to 1mn doses now going to Mexico. 👍 reuters.com/business/healt…
3) EU exports continue to rise rapidly and reached - once the earliest shipments in Dec 2020-Jan 2021 are included in the data - ~161mn by late Apr with 148mn since Jan 31st 2021 alone bloomberg.com/news/articles/…
4) India in a devastating 2nd wave has (sensibly) halted vacc exports and may begin to import finished vaccs in addition to ingredients already flowing. China meanwhile ramps up vacc'ing and exports, but will also soon being to import 100mn @pfizer vaccs wsj.com/articles/china…
5) Overall ~1.25bn vaccs have by last week of Apr 2021 been produced in the global "Big-4" - China, EU27, U.S. and India. Great news! The top-2 China (~415mn) and EU27 (325mn) have broadly a 50-50 split between domestic deliveries and exports in their total located production.
6) India (~200mn) to date exported roughly 1/3, but has now (sensibly) stopped so % will drop fast, while the 3rd largest global producer in the US (~310mn) has to date exported virtually nothing, as @joebiden (like his predecessor) literally has put "Americans First"
7) In global supply terms UK is a trivial vacc producer, having imported roughly as many doses (from EU27 and India) as it has produced domestically, while no data is available for Russian or other emerging vaccine producers.
8) More geographic detail is available for recent shipments from EU27 locations with JPN (52mn... go #TokyoOlympics!!!), NAFTA (24mn) and the UK (17mn) the largest destinations, while the US stockpile of unused FDA-approved (PFizer/Moderna/J&J) vaccines has now reached 68mn.
9) The US also has perhaps 40-50mn doses of @AstraZeneca vaccines more or less ready, but the Biden Admin will only release them as "as they become available over the next two months", a far too conservative approach it seems with India situation in mind! whitehouse.gov/briefing-room/…
10) Much better news for exports from EU27 locations, where depending on your assumptions for monthly or weekly trends continuing, levels should reach 250-300mn by end-Q2. By then EU27 looks likely to be #1GlobalCovidVaccineExportLocation in the world! 👍👍
11) But what is the @EU_Commission@vonderleyen@MamerEric doing to highlight this extraordinary vaccine production success (recall that EU27+NO+IS will also receive ~400-450mn by end-Q2)? Sadly no coherent positive vaccine narrative has been formulated, despite the great news!
12) While EU comms hence remain timid, @POTUS in his recent speech to Congress played up the FDR-comparisons and eloquently mused about "America as arsenal for vaccines for other countries"... despite having to date exported ~zero. :-) #Chutzpah!!! nytimes.com/2021/04/29/us/…
"We don't have enough to be confident to send it abroad"? This is absurd from @POTUS and US vaccine nationalism at its clearest. Consider what amount of vaccines the US has "on the shelves" now, what it has sent to others and what say the EU has done to date? 🧵
1) The US has per the @CDCgov a current unused stockpile of ~63mn FDA approved vacc doses (@Pfizer/ @moderna_tx / J&J), number that due to slowing vaccination rates as Americans who want it has already got it is rising at over 1mn/day.... covid.cdc.gov/covid-data-tra…
2) On top of that US medical experts estimate that the US now has 35-40mn non-FDA approved @AstraZeneca vaccines in storage, that it (given its focus on mRNA vaccines and AZ's side effects) is highly unlikely to ever use
Time to update the EU Covid vaccine charts. Situation is one of remarkable similarity across EU+NO+IS - with only HU (RU/CH vaccs) and MT (small size) well ahead of rest and BG, LV and CR materially lagging behind EU average. US (now ahead of UK) is well ahead of EU average. 1/n
The relative similarity of majority of EU MS' vacc levels is good news and indicates most MS are using essentially all the vaccines they receive now. Bodes well for ability to scale up as supplies increase. EU contrast to diff. vacc rates among US states is remarkable. 2/n
Focus on "elderly priority groups" highlights that UK program really, really well executed across old ages groups now for 1. jabs, but also that recent US "vacc surge" still leaves many elderly Americans behind, as some EU members have jabbed more elderly than the US 3/n
Time to update EU vaccination data; A clearer pic is emerging with MT and HU well ahead due to threshold and timing effect on vacc deliveries (MT) and RU/CH supply (HU), while BG, LV and CR lag behind EU average (Note - NL data a week old) 1/10
Apart from MT/HU at top and BG/LV/CR at bottom, rest of EU27+NO+IS increasingly clustering in the middle as some earlier frontrunners (DK/NO) suspend AZ vaccinations. This = best practices spreading and binding vacc supply (AZ overreliance?) constraints in BG/LV/CR. 2/10
A good news story is - despite it all - the acceleration in FR vaccinations, as gov appears to be using virtually all vaccs as they become available. Simple model suggests (if maintained) FR levels ~225k/day next 14days rising to ~385k/day after Apr 11 for rest of Apr 3/10
@vonderleyen was earlier today kind enough to update EU vaccine supply data. This was actually very very encouraging, as it highlights that the EU27+NO+IS is on target to be able to vaccinate 70% of its 18y+ population by the END OF JUNE with the 4 currently approved vaccines 1/n
Moreover, IF you assume the EU had adopted the UK/US "NO Exports stance" Q1 supply would have been 144mn (not 100mn) and assuming no export + @AstraZeneca contract compliance would yielded ~200mn in Q1 for the EU+NO+IS, or about double the actual 100mn. 2/n
Crucially, actual Q2 supply (if you x2 J&J supply to make them comparable) will be 410mn doses, rising to 520mn if @AstraZeneca had adhered to its contract. EU exports in Q2 are obviously not known yet. 3/n
Hvad skal EU - og derfor DK - goere for at undgaa at den nuvaerende vaccine situation gentages i en fremtidig pandemi som naeppe er 100aar vaek? Det drejer sig om penge og om at EU har nok af dem fra start - mit forslag fra @PIIE + traad #DKpol#dkmedierpiie.com/blogs/realtime…
EU har allerede en af verdens stoerste pharma-sektorer og er verdens stoerste producent/eksportoer af vacciner, saa alle ingredienserne er her allerede. Den tilstraekkelige mobilisering kraever blot en mere offensiv EU politik end noget stoerre parti i DK @Spolitik@venstredk 2/9
har haft fantasi til i aartier - desvaerre! Enhver global pandemi vil altid give flaskehalse og alles-kamp-mod-alle saa snart en vaccine er udviklet. Vacciner er risikable og dyre at udvikle, hvorfor indkoeberen skal have evnen til at tage store finansielle risici saa tidligt 3/9
What lessons should the EU and its member states learn to prevent its current troubled vaccine rollout from being repeated in a future where pandemics seem likely to be more frequent? In a new @PIIE piece, I lay out why it is mostly about money! 1/7 piie.com/blogs/realtime…
In any pandemic where vaccines are quickly and successfully developed, it is invariable that supply constraints and a "zero sum" game develop among advanced economies desperate to inoculate their populations. Having, as the EU does, a large domestic pharma-sector is an 2/7
obvious important advantage, but arguably more important is the ability, which the @EU_Commission does currently NOT have, to take large financial/fiscal risks early in the pandemic to ASAP support R&D, scale up production capacity and secure vaccines. The US with Operation 3/7